期刊文献+

姜黄素对肠炎大鼠肠黏膜基质金属蛋白酶-9的调控 被引量:14

Curcumin controls matrix metalloproteinase expression in colonic mucosa of rats with trinitrobenzene sulfonic acid-induced colitis
下载PDF
导出
摘要 目的:探索姜黄素对炎症性肠病(IBD)模型大鼠肠黏膜炎症靶点基质金属蛋白酶(MMP)-9的影响.方法:建立以三硝基苯磺酸诱导的大鼠IBD模型.模型大鼠给予含20g/L姜黄素的饲料喂养,药物对照组给予含2g/LN乙酰半胱氨酸和5g/L柳氮磺胺吡啶的饲料喂养,模型组及正常对照组给予普通饲料喂养.评价肠炎大鼠死亡率及肠黏膜病理组织学评分.电泳迁移率改变分析法检测肠黏膜胞核NFκB活性的变化.应用Western印迹分析法检测肠黏膜细胞质IκB.半定量RTPCR检测MMP9mRNA的表达.结果:姜黄素可降低IBD模型大鼠死亡率及改善肠黏膜病理组织学症状.姜黄素可抑制IBD模型大鼠肠黏膜胞质IκB的降解并抑制胞核NF-κB的激活,同时降低MMP-9的表达.结论:姜黄素可预防和改善IBD鼠科模型中的实验性肠炎,调控MMP9的表达;MMP9可作为观察抗肠炎药物药效的指标之一,姜黄素对治疗IBD有应用前景. AIM: To ascertain effects of NF-κB inhibitor curcumin on matrix metalloproteinase (MMP)-9 expression in the colonic mucosa of rats with trinitrobenzene sulfonic acid (TNBS)-induced colitis so as to screen out an anti-inflammatory target of curcumin. METHODS: Rats with TNBS-induced colitis were given a diet with 20 g/L curcumin. The medicine control rats were given a diet with 2 g/L N-acetylcysteine (NAC) and 5 g/L sulfasalazine (SASP) and the normal control rats and model rats were fed with regular diet. The changes in colonic mucosal histological scores and mortality were evaluated and the cell nuclear NF-κB activity in the colonic mucosa was evaluated by electrophoretic mobility shift assay. The cytoplasmic IκB protein in colonic mucosa was detected by Western Blot analysis and the MMP-9 messenger expressions in colonic tissue were assessed by semiquantitative reverse-transcription polymerase chain reaction. RESULTS: Degradations of cytoplasmic IκB protein in colonic mucosa were blocked by curcumin treatment. NF-κB activation in colonic mucosa was suppressed and the MMP-9 expression in colonic mucosa reduced in the curcumin-treated groups. Treatment with curcumin ameliorated the mortality and histopathologic signs of rats with TNBS-induced intestinal inflammation. CONCLUSIONS: NF-kappaB inhibitor, curcumin, can prevent and ameliorate experimental colitis in rats. MMP-9 expression can be controlled by curcumin. MMP-9 can be a medicine target for inflammatory bowel diseases.
出处 《第四军医大学学报》 北大核心 2005年第14期1257-1260,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30270078) 广东省中医药局基金(1040191)
关键词 炎性肠疾病 姜黄素 大鼠 疾病模型 动物 MMP-9 inflammatory bowel diseases curcumin rats disease models, animal MMP-9
  • 相关文献

参考文献9

  • 1Heuschkel RB, MacDonald TT, Montleone G, et al. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease[ J]. Gut, 2000 ;47:57 - 62.
  • 2Patel RT, Bain I, Youngs D, et al. Cytokine production in pouchitis is similar to that in ulcerative colitis [ J]. Dis Colon Rectum, 1995;38:831 - 837.
  • 3Neurath MF, Fuss I, Kelsall BL, et al. Antibodies to interleukin 12 abrogate established experimental colitis in mice [ J ]. J Exp Med,1995; 182(5 ): 1281 - 1290.
  • 4许小平,史剑慧,李林,张宗梁,程文英.白血病细胞核因子-κB活化与化疗药物诱导凋亡的关系[J].中华肿瘤杂志,2003,25(3):216-219. 被引量:11
  • 5Podolsky DK. Healing the epithelium: Solving the problem from two sides [ J]. J Gastroenterol, 1997 ;32:122 - 126.
  • 6Lampe B, Barthel B, Coupland SE, et al. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease [ J ]. Gut, 2000; 47:63 - 73.
  • 7Matsuno K, Adachi Y, Yamamoto H, et al. The expression of matrix metalloproteinase matrilysin indicates the degree of inflammation in ulcerative colitis [ J ]. J Gastroenterol, 2003; 38 (4): 348 - 354.
  • 8Monaco C, Andreakos E, Kiriakidis S, et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis [ J]. Proc Natl Acad Sci USA, 2004;101 (15) :5634 -5639.
  • 9Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokinemediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I kappa B kinase activity [ J ]. J Immunol, 1999;163(6): 3474 -3483.

二级参考文献9

  • 1Feuillard J, Schuhmacher M, Kohanna S, et al. Inducible loss of NF-κB activity is associated with apoptosis and bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood, 2000,95:2068-2075.
  • 2Wang CY, Cusack JC Jr, Liu R, et al. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB. Nat Med,1999,5:412-417.
  • 3El-Sabban ME, Nasr R, Dbaibo G, et al. Arsenic-interferon-α-triggered apoptosis in HTLV-transformed cells is associated with tax down-regulation and reversal of NF-κB activation. Blood, 2000,96:2849-2855.
  • 4Gong J,Traganos F, Darzynkiewicz Z. A selective procedure for DNA extraction from apoptosis cells applicable for gel electrophoresis and flow cytometry. Anal Biochem, 1994,218: 314-319.
  • 5Reuther JY,Reuther GW,Cortez D, et al. A requirement for NF-κB activation in Bcr-Abl-mediated transformation. Genes Dev, 1998,12:968-981.
  • 6Keller SA, Schattner EJ, Cesarman E. Inhibition of NF-κB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 2000,96:2537-2542.
  • 7Estrov Z, Manna SK, Harris D, et al. Phenylarsine oxide blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells. Blood, 1999, 94:2844-2853.
  • 8Cusack JC Jr, Liu R, Houston M, et al. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-κB inhibition. Cancer Res, 2001,61:3535-3540.
  • 9史剑慧,许小平,程文英,罗伟华,王健民,丁训杰.白血病细胞p53和bcl-2表达与化疗药物诱导凋亡的关系[J].中华内科杂志,2000,39(3):181-184. 被引量:8

共引文献10

同被引文献132

引证文献14

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部